These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial. Todi VK, Lodha R, Kabra SK. Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464 [Abstract] [Full Text] [Related]
4. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. Camargo CA, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF. J Allergy Clin Immunol; 2010 Feb; 125(2):374-80. PubMed ID: 20159247 [Abstract] [Full Text] [Related]
8. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM. Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579 [Abstract] [Full Text] [Related]
9. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA. Curr Med Res Opin; 2001 May; 17(2):96-104. PubMed ID: 11759189 [Abstract] [Full Text] [Related]
10. The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma. Philip G, Villarán C, Shah SR, Vandormael K, Smugar SS, Reiss TF. J Asthma; 2011 Jun; 48(5):495-502. PubMed ID: 21545249 [Abstract] [Full Text] [Related]
13. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group. J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681 [Abstract] [Full Text] [Related]
16. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Bukstein DA, Luskin AT, Bernstein A. Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136 [Abstract] [Full Text] [Related]
17. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM, Lambert K, Sears MR. Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511 [Abstract] [Full Text] [Related]
18. Effectiveness of montelukast in the treatment of cough variant asthma. Spector SL, Tan RA. Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381 [Abstract] [Full Text] [Related]
19. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL. Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819 [Abstract] [Full Text] [Related]
20. Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial. Schuh S, Willan AR, Stephens D, Dick PT, Coates A. J Pediatr; 2009 Dec; 155(6):795-800. PubMed ID: 19656525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]